List of Immune Design patents

List of Immune Design patents

List of IMMERSION MEDICAL, INC. patents

List of SensAble Technologies patents

List of Tufts University School of Medicine patents

List of motor vehicle parts manufacturing products

List of companies in Moore Venture Partners's investment portfolio

Patents where

Current Assignee

Name

is

Immune Design

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9044420 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses	Patent 9044420 was granted and assigned to Immune Design on June, 2015 by the United States Patent and Trademark Office.		Immune Design		United States Patent and Trademark Office	9044420	June 2, 2015
	‌ US Patent 11365230 Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof		Immune Design	Immune Design		United States Patent and Trademark Office	11365230	June 21, 2022
	‌ US Patent 8957047 GLA monotherapy for use in cancer treatment	Patent 8957047 was granted and assigned to Immune Design on February, 2015 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	8957047	February 17, 2015
	‌ US Patent 9555099 Vaccines for HSV-2	Patent 9555099 was granted and assigned to Immune Design on January, 2017 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	9555099	January 31, 2017
	‌ US Patent 8187872 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein	Patent 8187872 was granted and assigned to Immune Design on May, 2012 by the United States Patent and Trademark Office.		Immune Design		United States Patent and Trademark Office	8187872	May 29, 2012
	‌ US Patent 9895435 Vaccines for HSV-2	Patent 9895435 was granted and assigned to Immune Design on February, 2018 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	9895435	February 20, 2018
	‌ US Patent 11135283 Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids	Patent 11135283 was granted and assigned to Immune Design on October, 2021 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	11135283	October 5, 2021
	‌ US Patent 10993999 Materials and methods for producing improved lentiviral vector particles	Patent 10993999 was granted and assigned to Immune Design on May, 2021 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10993999	May 4, 2021
	‌ US Patent 8962593 GLA monotherapy for use in cancer treatment	Patent 8962593 was granted and assigned to Immune Design on February, 2015 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	8962593	February 24, 2015
	‌ US Patent 10584356 Multigenome retroviral vector preparations and methods and systems for producing and using same	Patent 10584356 was granted and assigned to Immune Design on March, 2020 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10584356	March 10, 2020
	‌ US Patent 10993956 GLA monotherapy for use in cancer treatment	Patent 10993956 was granted and assigned to Immune Design on May, 2021 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10993956	May 4, 2021
	‌ US Patent 10391157 Materials and methods for producing improved lentiviral vector particles	Patent 10391157 was granted and assigned to Immune Design on August, 2019 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10391157	August 27, 2019
	‌ US Patent 10179919 Multigenome retroviral vector preparations and methods and systems for producing and using same	Patent 10179919 was granted and assigned to Immune Design on January, 2019 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10179919	January 15, 2019
	‌ US Patent 9713635 Materials and methods for producing improved lentiviral vector particles	Patent 9713635 was granted and assigned to Immune Design on July, 2017 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	9713635	July 25, 2017
	‌ US Patent 10391164 Vaccines for HSV-2	Patent 10391164 was granted and assigned to Immune Design on August, 2019 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10391164	August 27, 2019
	‌ US Patent 10342815 GLA monotherapy for use in cancer treatment	Patent 10342815 was granted and assigned to Immune Design on July, 2019 by the United States Patent and Trademark Office.	Immune Design	Immune Design		United States Patent and Trademark Office	10342815	July 9, 2019
	‌ US Patent 8323662 Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein			Immune Design		United States Patent and Trademark Office	8323662	December 4, 2012

17 results

0 selected

17 results

0 selected